Development and implementation of mindfulness-based psychological intervention program on premenstrual dysphoric symptoms and quality of life among late adolescents: A pilot study

Puthusserry, Shyla Thomas; Delariarte, Clarissa F.

doi:10.1016/j.jadr.2022.100461

Cited by 2 publications

(3 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This is consistent with a survey of 385 medical students, where an increase in PMS symptoms such as emotional disturbance, weakness, mastalgia and sleep disturbance during the pandemic was observed [ 31 ]. In addition, a study of 400 college students identified a 19% increase in the prevalence of premenstrual dysphoric disorder and 43.3% uptake of premenstrual syndrome amongst the cohort during the pandemic [ 34 ]. This is perhaps unsurprising, given that PMS symptoms are often related to stressful events [ 35 , 36 ].…”

Section: Discussionmentioning

confidence: 99%

The menstrual cycle and the COVID-19 pandemic

Mitra,

Verbakel,

Kasaven

et al. 2023

PLoS ONE

View full text Add to dashboard Cite

Background The impact of COVID-19 virus on menstrual cycles in unvaccinated women is limited. Objective To investigate the prevalence of changes to menstrual cycle characteristics, hormonal symptoms and lifestyle changes prior to and during the COVID-19 pandemic. Methods A retrospective online cross-sectional survey completed by social media users between July 2020 to October 2020. Participants were living in the United Kingdom (UK), premenopausal status and, or over 18 years of age. Main outcome(s) and measures(s) The primary outcome was to assess changes to menstrual cycle characteristics during the pandemic following the Checklist for Reporting Results of Internet E-Surveys (CHERRIES). Secondary outcomes included assessment of hormonal and lifestyle changes. Results 15,611 social media users completed the survey. Of which, 75% of participants experienced a change in their menstrual cycle, with significantly greater proportions reporting irregular menstrual cycles (P<0·001), bleeding duration more than seven days (P<0·001), longer mean cycle length (P<0·001) and overall bleeding duration (P<0·001). Over half the participants reported worsening of premenstrual symptoms including low mood/depression, anxiety and irritability. When stratified according to COVID-19 infection, there was no significant difference in menstrual cycle changes. Conclusion The COVID-19 pandemic resulted in considerable variation in menstrual cycle characteristics and hormonal symptoms. This appears to be related to societal and lifestyle changes resulting from the pandemic, rather than to the virus itself. We believe this may have an impact on the individual, as well as national economy, healthcare, and population levels, and therefore suggest this should be taken into consideration by governments, healthcare providers and employers when developing pandemic recovery plans.

show abstract

Section: Discussionmentioning

confidence: 99%

The menstrual cycle and the COVID-19 pandemic

Mitra,

Verbakel,

Kasaven

et al. 2023

PLoS ONE

View full text Add to dashboard Cite

show abstract

“…remenstrual dysphoric disorder (PMDD) encompasses a cyclic occurrence of physical, cognitive, emotional, and behavioral symptoms during the luteal phase of the menstrual cycle that subside with the onset of menstruation or shortly thereafter (Puthusserry & Delariarte, 2023). Studies have shown that while 75% of women in their reproductive years are affected by premenstrual symptoms (Kulkarni et al, 2022), between 5 to 8% suffer from severe forms of the disorder, impacting 3 to 8% of women per menstrual cycle (Acikgoz et al, 2017;Erbil & Yücesoy, 2023).…”

Section: Introductionmentioning

confidence: 99%

“…A range of biopsychomedical interventions such as antidepressants, anti-anxiety medications, and hormonal treatments are employed (Sharma et al, 2022); although these may reduce premenstrual symptoms, none address the complex underlying mechanisms of premenstrual distress and discomfort (Kulkarni et al, 2022). Consequently, psychological and non-pharmacological treatments have been developed to improve and alleviate the symptoms of premenstrual disorders, including metacognitive therapy (Puthusserry & Delariarte, 2023). This model suggests that negative thoughts and feelings are transient; however, when an individual responds to them with cognitive attention syndrome, it may lead to prolonged psychological distress and unintentionally exacerbate negative affect (Batmaz & Altınöz, 2023).…”

Section: Introductionmentioning

confidence: 99%

The Effectiveness of Metacognitive Therapy on Dysfunctionalities in Women with Premenstrual Dysphoric Disorder

Derakhshan Roudsari

2024

AFTJ

View full text Add to dashboard Cite

Objective: The aim of this study was to evaluate the effectiveness of metacognitive therapy on dysfunctions in women suffering from premenstrual dysphoric disorder. Method: This quasi-experimental research used a pre-test, post-test, and follow-up design with a control group. The population consisted of female dentistry students at the Islamic Azad University diagnosed with premenstrual dysphoric disorder in 2022. A sample of 30 women was selected through convenience sampling. The experimental group received metacognitive training over 12 sessions lasting 60 minutes each week, while the control group was placed on a waiting list. Data were collected using the Weisman and Beck Dysfunctional Attitude Scale (1987) and analyzed using repeated measures ANOVA through SPSS software. Findings: Results indicated that metacognitive therapy was effective in reducing dysfunctions. The eta-squared statistic also suggested that approximately 24.3% of the reduction in dysfunctions was attributable to the effectiveness of metacognitive therapy. Conclusions: Metacognitive therapy can be deemed effective in treating dysfunctions in women with premenstrual dysphoric disorder and can be used to alleviate psychological problems in these patients.

show abstract

Development and implementation of mindfulness-based psychological intervention program on premenstrual dysphoric symptoms and quality of life among late adolescents: A pilot study

Cited by 2 publications

References 22 publications

The menstrual cycle and the COVID-19 pandemic

The menstrual cycle and the COVID-19 pandemic

The Effectiveness of Metacognitive Therapy on Dysfunctionalities in Women with Premenstrual Dysphoric Disorder

Contact Info

Product

Resources

About